The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, Kihealth raised $5 million in seed funding to launch its early detection test.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback